22NW, LP – Merrimack Pharmaceuticals, Inc. Transaction History
22NW, LP portfolio value:
$4.61M
portfolio value
22NW, LP quarter portfolio value change:
-36.97%
quarter
Merrimack Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.88% | -10.88K shares | -2.77M | $3.75 | 1.23M |
| Q2 2022 | share | 0.00% | 0 shares | -466K | $5.95 | 1.24M | |
| Q1 2022 | share | 0.00% | 0 shares | 2.99M | $6.33 | 1.24M | |
| Q4 2021 | share | 0.00% | 0 shares | -1.14M | $3.93 | 1.24M | |
| Q3 2021 | share | 0.00% | 0 shares | -1.93M | $4.83 | 1.24M | |
| Q2 2021 | share | 0.00% | 0 shares | 137K | $6.39 | 1.24M | |
| Q1 2021 | share | 0.00% | 0 shares | -758K | $6.28 | 1.24M | |
| Q4 2020 | share | 0.00% | 0 shares | 3.58M | $6.89 | 1.24M | |
| Q3 2020 | share | 0.00% | 0 shares | 832K | $4 | 1.24M | |
| Q2 2020 | share | 0.00% | 0 shares | 1.46M | $3.33 | 1.24M | |
| Q1 2020 | share | 0.00% | 0 shares | -1.24M | $2.15 | 1.24M | |
| Q4 2019 | share | 0.00% | 0 shares | -1.67M | $3.15 | 1.24M | |
| Q3 2019 | share | Decrease | -21.32% | -336.55K shares | -1.92M | $3.98 | 1.24M |
| Q2 2019 | share | Increase | +13.70% | 190.18K shares | -78K | $3.32 | 1.57M |
| Q1 2019 | share | Increase | +45.77% | 435.90K shares | 4.69M | $3.82 | 1.38M |
| Q4 2018 | share | Increase | 0.00% | 952.36K shares | 2.89M | $2.12 | 952.36K |